Pay in 4 interest-free payments of $6.25 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
A licensed healthcare provider can determine what (if any) treatment is appropriate for you
In the recently published SURMOUNT-5 trial, which evaluated weight reduction over 72 weeks with the maximum tolerated dose of tirzepatide (10 or 15 mg) vs semaglutide (1.7 or 2.4 mg) in adults with obesity without type 2 diabetes, tirzepatide showed superior efficacy
Mike Doustdar , Novo Nordisk CEO and president Novo Nordisk CEO and President Mike Doustdar said, This agreement with Hims & Hers is a meaningful win for patients in the United States
Keep scheduled followups (virtual or inperson) to monitor progress, manage side effects, and make dosing changes as needed
US$ 20.86
US$ 25.79
US$ 25.40
US$ 28.43
US$ 25.56
US$ 27.17
US$ 24.50
US$ 27.42
US$ 22.39
